Sarcopenia Prevention Study: A Targeted Exercise and Protein Supplementation Program for Elderly Indians (STEPS STUDY)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2019 - 2025
Project Lead
Dr Sucharitha S
Authors
Dr Sucharita S, Dr Arvind K, Dr Tony DS
Project Status
completed
Project Type
ICMR